A Louisiana man filed a lawsuit in U.S. District Court against Eli Lilly and Co., claiming he developed diabetes as a result of using the popular atypical antipsychotic drug Zyprexa. The man took Zyprexa for two years and developed severe diabetes. The lawsuit argues that Eli Lilly did not give proper warning that the drug could be linked to diabetes and other serious side effects.
Zyprexa is a leading atypical anti-psychotic drug which is also known as olanzapine. The drug approved by the U.S. Food and Drug Administration in 1996 to treat schizophrenia and bipolar disorder. In 2004, Eli Lilly began including strong warning labels with Zyprexa regarding an increased risk of hyperglycemia and diabetes, especially in patients with a family history of diabetes. In 2005, Eli Lilly agreed to pay plaintiffs $690 million to settle thousands of Zyprexa claims.
Other popular atypical ant-psychotics include Risperdal, Seroquel, Clozaril and Geodon. Risperdal, Seroquel and Clozaril have all been associated with diabetes and other blood sugar disorders. Numerous lawsuits have also been filed against the manufacturers of these drugs.